TNYA (STOCKS)
Tenaya Therapeutics, Inc. Common Stock
$0.689100
+0.009400 (+1.38%)
Prev close: $0.679700
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Faraz Ali
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $148.03M
- Employees
- 97
- P/E (TTM)
- -0.87
- P/B (TTM)
- 1.35
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
9
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.12 | $-0.15 | +0.0307 | +20.37% |
|
Jun 2025 (Q2)
|
$-0.14 | $-0.26 | +0.1150 | +45.10% |
|
Mar 2025 (Q1)
|
$-0.24 | $-0.19 | -0.0462 | -23.84% |
|
Dec 2024 (Q4)
|
$-0.28 | $-0.32 | +0.0373 | +11.76% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $2.95M |
| Operating Expenses | $97.21M |
| Depreciation and Amortization | $8.80M |
| Research and Development | $72.50M |
| Other Operating Expenses | $15.91M |
| Operating Income/Loss | -$97.21M |
| Income/Loss From Continuing Operations After Tax | -$94.26M |
| Income/Loss From Continuing Operations Before Tax | -$94.26M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$94.26M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$94.26M |
| Net Income/Loss Available To Common Stockholders, Basic | -$94.26M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.75 |
| Diluted Earnings Per Share | -$0.75 |
| Basic Average Shares | 146,063,216 |
| Diluted Average Shares | 146,063,216 |
| Assets | $104.98M |
| Current Assets | $61.24M |
| Cash | $56.30M |
| Prepaid Expenses | $3.94M |
| Other Current Assets | $1.00M |
| Noncurrent Assets | $43.74M |
| Fixed Assets | $29.44M |
| Other Non-current Assets | $14.30M |
| Liabilities | $22.11M |
| Current Liabilities | $13.21M |
| Accounts Payable | $2.84M |
| Other Current Liabilities | $10.37M |
| Noncurrent Liabilities | $8.90M |
| Equity | $82.87M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $82.87M |
| Liabilities And Equity | $104.98M |
| Net Cash Flow From Operating Activities | -$72.71M |
| Net Cash Flow From Operating Activities, Continuing | -$72.71M |
| Net Cash Flow From Investing Activities | $70.25M |
| Net Cash Flow From Investing Activities, Continuing | $70.25M |
| Net Cash Flow From Financing Activities | $50.54M |
| Net Cash Flow From Financing Activities, Continuing | $50.54M |
| Net Cash Flow | $48.08M |
| Net Cash Flow, Continuing | $48.08M |
| Comprehensive Income/Loss | -$94.33M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$94.33M |
| Other Comprehensive Income/Loss | -$76.00K |